SCAN-MED AS NORWAY

3048 DRAMMEN

Finances

Return on Equity

18,89 %

Current Ratio

6,36

Debt-to-Equity Ratio

0,12

Key figures (NOK)	2022	2021	2020	2019
Revenue	76 654 000	76 016 000	72 526 000	58 544 000
Net Income	23 745 000	21 344 000	15 516 000	9 750 000
Total Assets	159 372 000	142 835 000	137 443 000	127 105 000
Total Equity	125 697 000	101 952 000	85 608 000	76 064 000

Income (NOK)	2022	2021	2020	2019
Revenue	76 654 000	76 016 000	72 526 000	58 544 000
Expenditure	59 328 000	60 675 000	54 997 000	49 995 000
Operating Profit	17 326 000	15 341 000	17 528 000	8 548 000
Financial Income	10 777 000	9 615 000	1 718 000	3 978 000
Financial Costs	381 000	225 000	−305 000	851 000
Financial Balance	10 396 000	9 390 000	2 023 000	3 127 000
Earnings Before Tax	27 722 000	24 732 000	19 552 000	11 674 000
Tax	3 977 000	3 388 000	4 036 000	1 924 000
Net Income	23 745 000	21 344 000	15 516 000	9 750 000

Balance (NOK)	2022	2021	2020	2019
Total Fixed Assets	40 723 000	40 800 000	41 328 000	39 132 000
Total Current Assets	118 650 000	102 035 000	96 115 000	87 973 000
Total Assets	159 372 000	142 835 000	137 443 000	127 105 000
Total Retained Equity	95 697 000	71 952 000	55 608 000	46 064 000
Total Equity	125 697 000	101 952 000	85 608 000	76 064 000
Total Long-Term Debt	15 028 000	20 085 000	29 915 000	422 000
Total Current Debt	18 647 000	20 798 000	21 921 000	50 619 000
Total Equity and Debt	159 372 000	142 835 000	137 443 000	127 105 000

Cash flow (NOK)	2022	2021	2020	2019
Sales Income	76 514 000	76 016 000	72 437 000	58 499 000
Other Income	140 000	0	89 000	45 000
Revenue	76 654 000	76 016 000	72 526 000	58 544 000
Cost of Goods Sold	42 838 000	43 863 000	37 903 000	33 325 000
Salary Costs	11 551 000	11 378 000	12 298 000	10 534 000
Depreciation	386 000	334 000	299 000	320 000
Impairment	0	0	0	0
Expenditure	59 328 000	60 675 000	54 997 000	49 995 000
Operating Profit	17 326 000	15 341 000	17 528 000	8 548 000
Financial Income	10 777 000	9 615 000	1 718 000	3 978 000
Financial Costs	381 000	225 000	−305 000	851 000
Financial Balance	10 396 000	9 390 000	2 023 000	3 127 000
Dividends	0	5 000 000	6 000 000	4 000 000
Net Income	23 745 000	21 344 000	15 516 000	9 750 000

Balance details (NOK)	2022	2021	2020	2019
Goodwill	0	0	0	0
Total Intangible Assets	361 000	463 000	575 000	720 000
Real Eastate	3 584 000	3 585 000	3 586 000	3 513 000
Machinery and Plant Facilities	0	0	0	0
Fixtures	2 514 000	1 669 000	1 885 000	1 048 000
Total Tangible Assets	6 099 000	5 254 000	5 471 000	4 561 000
Total Fiancial Fixed Assets	34 263 000	35 083 000	35 282 000	33 851 000
Total Fixed Assets	40 723 000	40 800 000	41 328 000	39 132 000
Stock	23 125 000	19 461 000	17 102 000	13 903 000
Total Investments	0	0	0	0
Cash, Bank	86 480 000	66 177 000	64 043 000	56 842 000
Total Current Assets	118 650 000	102 035 000	96 115 000	87 973 000
Total Assets	159 372 000	142 835 000	137 443 000	127 105 000
Total Equity	125 697 000	101 952 000	85 608 000	76 064 000
Short-Term Group Debt	521 000	521 000	521 000	0
Total Long-Term Debt	15 028 000	20 085 000	29 915 000	422 000
Creditors	2 580 000	6 449 000	4 711 000	3 619 000
Unpaid Taxes	3 755 000	3 879 000	4 428 000	3 058 000
Dividends	0	5 000 000	6 000 000	4 000 000
Other Current Debt	7 916 000	1 672 000	2 398 000	38 087 000
Total Current Debt	18 647 000	20 798 000	21 921 000	50 619 000
Total Equity and Debt	159 372 000	142 835 000	137 443 000	127 105 000

Financial indicators	2022	2021	2020	2019
Return on Equity	18,89 %	20,94 %	18,12 %	12,82 %
Debt-to-Equity Ratio	0,12	0,2	0,35	0,01
Operating Profit Margin	22,6 %	20,18 %	24,17 %	14,6 %
Current Ratio	6,36	4,91	4,38	1,74
Quick Ratio	−26,5	76,32	19,95	2,4
Equity Ratio	0,79	0,71	0,62	0,6
Gross Profit Margin	44,12 %	42,3 %	47,74 %	43,08 %